Latest Non Dilutive Funding News

BLS Pharmaceuticals (ASX: BLS) reported a standout FY26 with revenue surging 161% to $74.2 million and net profit more than tripling to $15.4 million, driven by expanded manufacturing and major international contracts including a $50 million German supply deal.

Actinogen Medical reported a $15.38 million loss for FY2026 while progressing its lead Alzheimer's drug Xanamem toward pivotal trial results expected this November. The company secured regulatory alignment and strengthened its cash position to fund operations through mid-2027.

Ore Resources Ltd (ASX: OR3) has released a robust Scoping Study for its Kangaroo Hills Lithium Project, outlining a low-capital, fast-track Direct Shipping Ore (DSO) operation expected to generate substantial cash flow within a 16-month mine life.

Bayan Mining has finalised the sale of its Bayan Springs North Project to Sun Silver, securing upfront and contingent payments while retaining a 1% royalty to maintain exposure to future exploration success.

Sinclair Gold has cleared a key drilling milestone at its Mt Henry project, prompting a $5 million cash payment to Westgold and cancelling over 7.5 million performance rights. The company also moves closer to completing a royalty deal with Stria Lithium, while preparing for a resource update by year-end.

EMVision Medical Devices has made significant strides in its emu™ bedside scanner pivotal trial and First Responder program, boosting FY26 revenue by 57% while trimming its net loss by 15%.

Latitude 66 has finalised the sale of its non-core Piastri Project to Capricorn Metals, converting the deal into approximately A$1.79 million in shares. Alongside a recent royalty portfolio sale, this boosts Latitude 66’s war chest with over A$5 million to fund core exploration in Finland and Western Australia.

Medallion Metals has raised A$60 million through a targeted placement, boosting its liquidity to about A$175 million and enabling accelerated development of its Ravensthorpe Gold Project and drilling programs in Western Australia.

Mont Royal Resources has bolstered its funding position with a C$2.22 million tax credit from Quebec, supporting advancement of its Ashram Rare Earth and Fluorspar Project toward a Pre-Feasibility Study.

Kinetiko Energy’s South African subsidiary has locked in a $1.26 million cash agreement with Mulilo, resolving land-use conflicts and gaining a potential gas supply edge for a major wind energy project.

Felix Gold's US subsidiary is in line for a substantial non-dilutive federal grant to advance its Treasure Creek antimony pilot processing facility, accelerating its plan for a domestic US supply chain.

Tusker Minerals has agreed to sell its Malawian rare earth assets to AuKing Mining for up to A$4.85 million, while retaining key rutile projects and upside exposure through equity stakes.